安定同位体標識化合物市場：タイプ別、合成法別、製剤別、用途別、エンドユーザー産業別-2025-2030年世界予測

安定同位体標識化合物市場は、2024年には3億2,153万米ドルとなり、2025年には3億3,513万米ドル、CAGR 4.25%で成長し、2030年には4億1,290万米ドルに達すると予測されています。

安定同位体標識化合物市場は、様々な科学的・産業的領域における用途の増加に牽引され、かつてないペースで進化しています。最近の動向では、安定同位体標識化合物は、代謝経路の追跡、化学構造の解明、臨床診断や医薬品開発における研究の進展に欠かせないものとなっています。このダイナミックな市場は、科学的な厳密さ、技術的な進歩、そして世界の産業における旺盛な需要が特徴です。分析手法の精度に対するニーズの高まりと研究開発の進歩が、これらの化合物への関心を高めています。合成技術や製剤技術の一貫した革新により、企業は現在、厳しい規制基準を満たす高品質の標識化合物を提供する体制を整えています。現在の情勢は、安定同位体標識化合物を現代の研究環境における礎石として位置づけ、学術、業界、臨床の追求の収束によって特徴づけられています。このイントロダクションでは、この重要なセグメントの将来を形成している市場シフト、セグメンテーションの複雑さ、地域ダイナミックス、競争力を包括的に調査するための舞台を整えます。

安定同位体標識化合物市場の変革

過去10年間、市場は、技術革新、規制改革、科学的分析における精度に対する世界の要求の高まりなどの影響を受け、大きく変化してきました。生物学的・化学的合成における新たなアプローチは生産技術を再定義し、純度、効率、費用対効果の向上を確実にしました。デジタル・プラットフォームとデータ分析の進化は、意思決定プロセスをさらに加速し、より機敏で適応性の高い手法を推進しました。老舗企業も新興企業も画期的な技術を採用し、製品提供の拡張性とカスタマイズ性を高めています。業界は、伝統的な手法から、高度な計測機器と自動化を活用した、より近代的な統合システムへと大きく移行しています。同時に、基礎研究と産業応用の相互作用が相乗的な共同研究をもたらし、イノベーションの迅速な市場参入を促進しています。こうした変革的なシフトは、技術的な枠組みを再定義するだけでなく、品質管理とコンプライアンスにおける新たなベンチマークを確立し、世界規模での競合差別化を促進しています。

安定同位体標識化合物の主なセグメンテーション洞察

市場セグメンテーションを分析すると、安定同位体標識化合物市場の進化するダイナミクスをより深く洞察する階層構造が見えてくる。第一に、炭素-13、重水素、窒素-15、酸素-18のような種類別に見ると、それぞれ様々な生化学的・工業的用途に重要な分析能力を提供しています。第二に、合成方法のセグメンテーションは、生物学的合成と化学的合成の両方が多様な研究ニーズと生産規模を満たす上で極めて重要な役割を果たす二重アプローチを示しています。第三に、製剤に関する洞察は、液体と固体の異なる特性と用途を明らかにし、それぞれの製剤は特定の最終用途の要求と分析環境に対応しています。さらに、アプリケーションベースのセグメンテーションにより、臨床診断、産業部門、研究・学術活動におけるこれらの化合物の重要性が強調されます。最後に、エンドユーザー産業セグメンテーションから得られる洞察は、化学産業、環境試験、飲食品セクター、病院・診断センター、製薬・バイオテクノロジーセクターなど、幅広い産業分野での化合物の採用を強調しています。各セグメンテーションの視点が絡み合うことで、市場規模、成長の可能性、各分野特有の課題に対応するテーラーメード製品への嗜好の進化に関する包括的な見解が示されます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 農業および食品安全試験における安定同位体標識化合物の統合の拡大
    • 臨床診断と正確な代謝経路研究における利用の増加
    • 研究開発分野における政府および民間の資金提供イニシアチブの増加
  • 抑制要因
    • 高い生産コストと前駆体材料の入手の制限
  • 機会
    • 高度で改良されたSILCを開発するための継続的な研究開発
    • 質量分析および液体クロマトグラフィーシステムの技術的進歩
  • 課題
    • 規制上のハードルとラベル作成プロセスの複雑さ
• 市場セグメンテーション分析
  • タイプ：安定性の向上と薬物動態の変化に対する重水素化合物の重要性の高まり
  • 応用：高精度の臨床診断における安定同位体標識化合物の応用拡大
  • 製造プロセス：化学合成により、さまざまな同位体を濃縮し、より高いレベルの標識化を達成するための柔軟性の向上を実現
  • 応用：SILCは科学調査の発見の改善と強化を促進する必要がある
  • エンドユーザー：多様な調査のためのより幅広いSILCの採用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 安定同位体標識化合物市場：タイプ別

• 炭素13
• 重水素
• 窒素15
• 酸素18

第7章 安定同位体標識化合物市場合成方法別

• 生物学的合成
• 化学合成

第8章 安定同位体標識化合物市場処方別

• 液体
• 固体

第9章 安定同位体標識化合物市場：用途別

• 臨床診断
• 産業
• 調査と学術

第10章 安定同位体標識化合物市場エンドユーザー業界別

• 化学産業
• 環境試験業界
• 飲食品
• 病院と診断センター
• 製薬・バイオテクノロジー

第11章 南北アメリカの安定同位体標識化合物市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の安定同位体標識化合物市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの安定同位体標識化合物市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Alfa Chemistry
• American Elements
• Atlanchim Pharma
• Avanti Polar Lipids, Inc. by Croda International PLC
• Bio-Techne
• Biosolve BV
• BOC Sciences
• Cambridge Isotope Laboratories, Inc.
• Charles River Laboratories International, Inc.
• CORTECNET SAS
• Curachem, Inc.
• Entegris, Inc
• Huayi Isotope Co.
• Isoflex Radioactive LLC
• LGC Limited
• Merck KGaA
• Mesbah Energy Company
• Nippon Sanso Holdings Corporation
• Omicron Biochemicals Inc.
• PerkinElmer Inc.
• Shanghai Research Institute of Chemical Industry
• Shoko Co. Ltd.
• Silantes GmbH
• Symeres
• Urenco Limited
• VIVAN Life Sciences

LIST OF FIGURES

• FIGURE 1. STABLE ISOTOPE LABELED COMPOUNDS MARKET MULTI-CURRENCY
• FIGURE 2. STABLE ISOTOPE LABELED COMPOUNDS MARKET MULTI-LANGUAGE
• FIGURE 3. STABLE ISOTOPE LABELED COMPOUNDS MARKET RESEARCH PROCESS
• FIGURE 4. STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. STABLE ISOTOPE LABELED COMPOUNDS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. STABLE ISOTOPE LABELED COMPOUNDS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. STABLE ISOTOPE LABELED COMPOUNDS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. STABLE ISOTOPE LABELED COMPOUNDS MARKET DYNAMICS
• TABLE 7. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY CARBON-13, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY DEUTERIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY NITROGEN-15, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY OXYGEN-18, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY BIOLOGICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY RESEARCH & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY CHEMICAL INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY ENVIRONMENTAL TESTING INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 46. CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 73. CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 78. INDIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 164. ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 184. POLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 189. QATAR STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM STABLE ISOTOPE LABELED COMPOUNDS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 237. STABLE ISOTOPE LABELED COMPOUNDS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 238. STABLE ISOTOPE LABELED COMPOUNDS MARKET, FPNV POSITIONING MATRIX, 2024

The Stable Isotope Labeled Compounds Market was valued at USD 321.53 million in 2024 and is projected to grow to USD 335.13 million in 2025, with a CAGR of 4.25%, reaching USD 412.90 million by 2030.

The market for stable isotope labeled compounds is evolving at an unprecedented pace, driven by increasing applications across various scientific and industrial domains. In recent years, these compounds have become indispensable in tracing metabolic pathways, elucidating chemical structures, and advancing research in clinical diagnostics and pharmaceutical development. This dynamic market is characterized by its scientific rigor, technical advancements, and robust demand across global industries. The growing need for precision in analytical methodologies and the advancement of research and development have spurred interest in these compounds. With consistent innovations in synthesis and formulation technologies, companies are now better equipped to deliver high-quality labeled compounds that meet stringent regulatory standards. The current landscape is marked by a convergence of academic, industrial, and clinical pursuits, positioning stable isotope labeled compounds as a cornerstone in contemporary research settings. This introduction sets the stage for a comprehensive exploration of market shifts, segmentation intricacies, regional dynamics, and competitive forces that are shaping the future of this vital segment.

Transformative Shifts in the Landscape

Over the last decade, the market has experienced transformative shifts largely influenced by technological innovation, regulatory reforms, and heightened global demand for precision in scientific analyses. New approaches in biological and chemical synthesis have redefined production techniques, ensuring improved purity, efficiency, and cost-effectiveness. The evolution of digital platforms and data analytics has further accelerated decision-making processes, driving more agile and adaptive methodologies. Established and emerging players have embraced breakthrough technologies, leading to enhanced scalability and customization of product offerings. The industry is witnessing a significant transition from traditional practices to more modern, integrated systems that leverage advanced instrumentation and automation. Concurrently, the interplay between fundamental research and industrial application has resulted in synergistic collaborations, facilitating faster market entry of innovations. These transformative shifts are not only redefining the technological framework but also establishing new benchmarks in quality control and compliance, thereby driving competitive differentiation on a global scale.

Key Segmentation Insights in Stable Isotope Labeled Compounds

Analysis of market segmentation reveals a layered construct that provides deeper insights into the evolving dynamics of the stable isotope labeled compounds market. First, when viewed from the type perspective, the market is dissected across variants such as Carbon-13, Deuterium, Nitrogen-15, and Oxygen-18, each offering distinct analytical capabilities critical for various biochemical and industrial applications. Second, the synthesis method segmentation illustrates a dual approach where both biological synthesis and chemical synthesis play pivotal roles in meeting diverse research needs and production scales. Third, formulation insights shed light on the differing properties and applications of liquid and solid forms, with each formulation catering to specific end-use requirements and analytical environments. Moving further, an application-based segmentation underscores the importance of these compounds in clinical diagnostics, the industrial sector, and research and academic endeavors. Finally, insights drawn from end user industry segmentation highlight the adoption of these compounds across a broad spectrum of industries that include the chemical industry, environmental testing, food and beverage sectors, hospitals and diagnostic centers, as well as pharmaceutical and biotechnology sectors. Each segmentation perspective intertwines to illustrate a comprehensive view of market size, growth potential, and the evolving preference for tailored products that meet sector-specific challenges.

Based on Type, market is studied across Carbon-13, Deuterium, Nitrogen-15, and Oxygen-18.

Based on Synthesis Method, market is studied across Biological Synthesis and Chemical Synthesis.

Based on Formulation, market is studied across Liquid and Solid.

Based on Application, market is studied across Clinical Diagnostics, Industrial, and Research & Academic.

Based on End User Industry, market is studied across Chemical Industry, Environmental Testing Industry, Food & Beverage, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology.

Key Regional Insights: Analyzing Global Growth

The global footprint of the stable isotope labeled compounds market is characterized by distinct regional trends that reflect local dynamics and varying levels of industrial advancement. In the Americas, technological adoption is robust, driven by substantial investments in biotechnology and clinical research. The confluence of regulatory support and the efficient commercialization of innovative compounds is bolstering market penetration in this region. Moving to Europe, Middle East, and Africa, a rich history of scientific research coupled with progressive governmental policies fosters a vibrant environment for the application of these compounds, particularly in academic and clinical diagnostic settings. This region demonstrates a balanced fusion of legacy expertise and forward-looking technological integration. In Asia-Pacific, rapid economic growth and an increasing emphasis on research and development are catalyzing market expansion. Here, heightened governmental initiatives and an ever-expanding industrial base are propelling the adoption of stable isotope labeled compounds across clinical, industrial, and environmental sectors. Each of these regions exhibits unique drivers and challenges, yet collectively, they contribute to a resilient, diversified global market landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights and Competitive Landscape

Market leaders and innovative newcomers play integral roles in defining the competitive structure of the stable isotope labeled compounds market. Prominent companies such as 3M Company, Alfa Chemistry, American Elements, Atlanchim Pharma, and Avanti Polar Lipids, Inc. by Croda International PLC have set rigorous benchmarks in product quality and innovation. Other influential players including Bio-Techne, Biosolve BV, and BOC Sciences continue to advance novel production techniques that cater to high-end research applications. Cambridge Isotope Laboratories, Inc. and Charles River Laboratories International, Inc. are known for their robust service networks and technical expertise, enabling them to meet diverse demands in both academic and industrial segments. In addition, organizations like CORTECNET SAS, Curachem, Inc., Entegris, Inc, and Huayi Isotope Co. exemplify operational excellence through strategic collaborations and extensive research infrastructures. Isoflex Radioactive LLC, LGC Limited, Merck KGaA, and Mesbah Energy Company demonstrate a steadfast commitment to technological advancement and regulatory compliance. Industry innovators such as Nippon Sanso Holdings Corporation, Omicron Biochemicals Inc., PerkinElmer Inc., Shanghai Research Institute of Chemical Industry, Shoko Co. Ltd., Silantes GmbH, Symeres, Urenco Limited, and VIVAN Life Sciences contribute to a diversified ecosystem where competition drives continuous improvement and adaptation. This multifaceted competitive landscape not only fosters innovation across research domains but also ensures that product offerings remain at the forefront of scientific precision and reliability.

The report delves into recent significant developments in the Stable Isotope Labeled Compounds Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Alfa Chemistry, American Elements, Atlanchim Pharma, Avanti Polar Lipids, Inc. by Croda International PLC, Bio-Techne, Biosolve BV, BOC Sciences, Cambridge Isotope Laboratories, Inc., Charles River Laboratories International, Inc., CORTECNET SAS, Curachem, Inc., Entegris, Inc, Huayi Isotope Co., Isoflex Radioactive LLC, LGC Limited, Merck KGaA, Mesbah Energy Company, Nippon Sanso Holdings Corporation, Omicron Biochemicals Inc., PerkinElmer Inc., Shanghai Research Institute of Chemical Industry, Shoko Co. Ltd., Silantes GmbH, Symeres, Urenco Limited, and VIVAN Life Sciences. Actionable Recommendations for Industry Leaders

For decision-makers striving to maintain a competitive edge in this dynamic market, several strategic recommendations are essential. It is crucial to invest in research and development programs that enhance synthesis techniques and formulation processes, ensuring that product quality remains consistently high. Embracing digital transformation and data-driven insights can further streamline production, reduce costs, and improve operational efficiency. Industry leaders should also explore strategic partnerships and collaborations with research institutions and technology innovators to foster open channels for innovation. As market demands evolve, there is a significant opportunity to diversify product portfolios to cater to emerging trends and specialized applications, particularly in areas such as clinical diagnostics and environmental testing. Enhancing regulatory compliance and quality assurance protocols will not only build trust with stakeholders but also enable a smoother transition when adopting new technologies. Additionally, companies should leverage market analytics to gain insights into geographical trends and consumer preferences, which can inform targeted marketing strategies and regional expansion initiatives. Fostering an agile business model with scalable solutions will be instrumental in adapting to future market fluctuations, ensuring long-term sustainability and strategic growth.

Conclusion: Navigating a Future of Innovation and Growth

The overall analysis of the stable isotope labeled compounds market underscores a period of rapid transformation and immense opportunity. As technological advancements continue to shape synthesis techniques and product formulations, the market is poised to respond to an ever-growing demand across diverse sectors. The interplay between segmented offerings, regional dynamics, and competitive strategies highlights a complex yet promising ecosystem where innovation is not just a goal but a continuous journey. Industry players, armed with new analytical tools and strategic insights, are better positioned than ever to address evolving regulatory requirements, optimize production processes, and deliver superior products that meet market expectations. The transformative shifts noted in technological developments, coupled with a comprehensive understanding of segmentation and regional growth factors, provide the necessary framework for sustained progress. In this rapidly evolving environment, maintaining focus on quality, compliance, and strategic investments will be key to unlocking new opportunities and driving future market success.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing integration of stable isotope labeled compounds in agricultural and food safety testing
    • 5.1.1.2. Rising utilization in clinical diagnostics and precise metabolic pathway studies
    • 5.1.1.3. Increased government and private funding initiatives in research and development sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High production cost & limited availability of precursor materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D to develop advanced and improved SILCs
    • 5.1.3.2. Technological advancements in mass spectrometry and liquid chromatography systems
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory hurdles and the complexity of labeling processes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising significance of deuterium compounds for improved stability and altered pharmacokinetics
  • 5.2.2. Application: Expanding application of stable isotope labeled compounds in clinical diagnostics for high precision
  • 5.2.3. Production Process: Provision of higher flexibility in terms of enriching different isotopes and achieving higher levels of labeling through chemical synthesis
  • 5.2.4. Application: Need for SILCs to facilitate improved and enhanced scientific research discoveries
  • 5.2.5. End-User: Adoption of a broader range of SILCs for diverse research
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Stable Isotope Labeled Compounds Market, by Type

• 6.1. Introduction
• 6.2. Carbon-13
• 6.3. Deuterium
• 6.4. Nitrogen-15
• 6.5. Oxygen-18

7. Stable Isotope Labeled Compounds Market, by Synthesis Method

• 7.1. Introduction
• 7.2. Biological Synthesis
• 7.3. Chemical Synthesis

8. Stable Isotope Labeled Compounds Market, by Formulation

• 8.1. Introduction
• 8.2. Liquid
• 8.3. Solid

9. Stable Isotope Labeled Compounds Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Industrial
• 9.4. Research & Academic

10. Stable Isotope Labeled Compounds Market, by End User Industry

• 10.1. Introduction
• 10.2. Chemical Industry
• 10.3. Environmental Testing Industry
• 10.4. Food & Beverage
• 10.5. Hospitals & Diagnostic Centers
• 10.6. Pharmaceutical & Biotechnology

11. Americas Stable Isotope Labeled Compounds Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Stable Isotope Labeled Compounds Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Stable Isotope Labeled Compounds Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Cambridge Isotope Laboratories acquired an additional 14.8 acres to ramp up isotope production
  • 14.3.2. Picarro's launch of the PI5310 analyzer marks a strategic transaction in strengthening atmospheric research capabilities
  • 14.3.3. Merck's five-year strategic agreement with the Heavy Water Board secures a vital supply of heavy water
  • 14.3.4. Fusion Pharmaceuticals Strengthens Actinium Supply with Onsite Isotope Production through Expanded BWXT Medical Collaboration
  • 14.3.5. ITM Follows Euro 255 Million ( USD 274.2 Million) Investment Round by Opening New Facility
  • 14.3.6. Cambridge Isotope Laboratories, Inc. Partners with ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Alfa Chemistry
• 3. American Elements
• 4. Atlanchim Pharma
• 5. Avanti Polar Lipids, Inc. by Croda International PLC
• 6. Bio-Techne
• 7. Biosolve BV
• 8. BOC Sciences
• 9. Cambridge Isotope Laboratories, Inc.
• 10. Charles River Laboratories International, Inc.
• 11. CORTECNET SAS
• 12. Curachem, Inc.
• 13. Entegris, Inc
• 14. Huayi Isotope Co.
• 15. Isoflex Radioactive LLC
• 16. LGC Limited
• 17. Merck KGaA
• 18. Mesbah Energy Company
• 19. Nippon Sanso Holdings Corporation
• 20. Omicron Biochemicals Inc.
• 21. PerkinElmer Inc.
• 22. Shanghai Research Institute of Chemical Industry
• 23. Shoko Co. Ltd.
• 24. Silantes GmbH
• 25. Symeres
• 26. Urenco Limited
• 27. VIVAN Life Sciences